October 9, 2013
The Canadian-based Valeant Pharmaceuticals International has announced that its wholly owned subsidiary, Valeant Canada LP, has received approval for the onychomycosis treatment efinaconazole (10% topical solution) in Canada. Efinaconazole was originally discovered by Kaken Pharmaceutical. In 2006, under the license...read more